EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Multiple center listing for organ transplantation in the United States: time to reform?

Emmanouil Giorgakis, Keren Ladin, Sher-Lu Pai, Dimitrios Moris, Esteban Calderon, Oya Andacoglu, Nazia Selzner, Paulo N Martins

Frontiers in Transplantation · 01.10.2025 · 4

DOI: 10.3389/frtra.2025.1677463 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Transplantation, online erschienen am 01.10.2025. Verfasst von Emmanouil Giorgakis und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Division of Transplant, UNC Chapel Hill, Chapel Hill, NC, United States. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Multiple listing (ML) allows transplant candidates to be registered at more than one transplant center. The United States (US) is the only country known to allow this practice (table 1). In Europe, ML is strictly forbidden(1). Although ML may support individual autonomy and choice—values deeply embedded in the American culture—it raises ethical dilemmas. Patients with greater financial means and mobility may be more capable of securing places on multiple transplant waitlists, allowing socioeconomic status to impact the probability of transplant. This opinion paper explores ML through the lens of the ethical principles of autonomy, equity, justice, and utility used in transplantation(2).

Background

Organ Procurement and Transplant Network (OPTN) requires transplant centers to notify candidates that ML is allowed (2–4)(5). Transplant centers may decide whether to accept a patient who has already been listed elsewhere(3). The Final Rule, a US National Policy that dictates the protocol for all deceased organ donations, states that "organs should be allocated across the widest possible geographic area, while accounang for the urgency of each recipient's need"(5). The American Medical AssociaKon Code of Medical Ethics asserts that "organs should be treated as a naaonal resource without geographical limitaaons unless the transportaaon of the organ would compromise its viability for transplantaaon"(6). ML has an extensive history in the OPTN(3). In August 1987, the OPTN Board of Directors passed a resolution to allow patients to ML. The policy almost instantly faced criticism primarily due to concerns over potential inequities from these multiple registrations. These concerns led to OPTN public comment invite, Ethics and OPTN Board of Director Meetings, which ultimately allowed for the 1987 resolution to persist. ML policy was brought to the forefront again in 1994 and in 2001, with similar concerns. In November 2003, the OPTN Board of Directors voted to not restrict the policy and approved amendments regarding better patient education on their right to pursue ML. Despite the 2003 decision, the ongoing controversy led to OPTN Ethics Committee analysis in early 2022, which delivered a White Paper on the Ethical Evaluation of ML(3). The Committee specifically distinguished between pursuing multiple evaluations and ML. It concluded that "retaining the existing ML policy does promote equitable access to transplantation". "Widespread availability of ML may undermine equity and utility" (…) "However encouraging ML for patients who are disproportionately difficult to match is ethically justifiable to promote their equal access to transplant"(3). Access to healthcare and organ transplantation vary significantly across the US(4-7). ML was introduced to combat geographic disparities through enabling patients to circumvent regional differences in organ availability and waitlist dynamics, which persist despite national allocation reforms such as the acuity circles policy(3,7,8). However, ML may be "good for a few, but no solution for the organ shortage"(9). There have been concerns over ML shifting inequities rather that providing a solution(9). Patients with private insurance and higher education are more likely to be listed and transplanted sooner compared to those with Medicaid or no insurance(10). A United Network for Organ Sharing (UNOS) analysis by Merion et al. on 81,481 kidney and 26,260 liver transplant candidates (1995-2000), identified approximately 5.8% of kidney transplant and 3.3% of LT candidates as multiple-listed(11). Non-white race, older age, non-private insurance, and lower educational level were associated with lower ML rates(11). Transplant rates were higher for ML candidates(11). Another UNOS study on 59,557 liver transplant candidates (2005 to 2011) showed 2.3% being multi-listed(8). Among these patients, 67.6% underwent transplant at the secondary listing Donation Service Areas. ML recipients had shorter wait-times, lower median Model for End-Stage Liver Disease (MELD) scores, were more likely to be white, college educated, and with private insurance(9). Other studies have shown that ML considerably improves transplant rates and survival on low MELD patients(7). A more recent analysis reports that ML outside the primary OPTN/UNOS region was more likely on patients with college-level of education (33% vs 21%; P

Schlagwörter

Stichwörter der Autor:innen

equityethicsmultiple listingorgan transplantationtransplant access

Autor:innen und Institutionen

  • Department of Surgery, Division of Transplant, UNC Chapel Hill, Chapel Hill, NC, United States.
  • Department of Community Health, Tufts University, Boston, MA, United States.
  • Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Jacksonville, FL, United States.
  • Transplant Surgery, Medstar Georgetown Transplant Institute, Washington, DC, United States.
  • Division of Transplant Surgery, Presbyterian/St. Luke's Medical Center, Denver, CO, United States.
  • Ajmera Transplant Center, University of Toronto, Toronto, ON, Canada.

Zitieren

APA

Giorgakis, E., Ladin, K., Pai, S. L., Moris, D., Calderon, E., Andacoglu, O., Selzner, N., & Martins, P. N. (2025). Multiple center listing for organ transplantation in the United States: time to reform?. Frontiers in Transplantation, 4. https://doi.org/10.3389/frtra.2025.1677463

Vancouver

Giorgakis E, Ladin K, Pai SL, Moris D, Calderon E, Andacoglu O, et al. Multiple center listing for organ transplantation in the United States: time to reform?. Frontiers in Transplantation. 2025;4. doi:10.3389/frtra.2025.1677463

BibTeX
@article{Giorgakis2025,
  author = {Giorgakis, Emmanouil and Ladin, Keren and Pai, Sher-Lu and Moris, Dimitrios and Calderon, Esteban and Andacoglu, Oya and Selzner, Nazia and Martins, Paulo N},
  title = {Multiple center listing for organ transplantation in the United States: time to reform?},
  journal = {Frontiers in Transplantation},
  year = {2025},
  volume = {4},
  doi = {10.3389/frtra.2025.1677463}
}
Kostenlos starten →